Blanca Fuentes Selected Research

Blanca Fuentes Research Topics

Disease

49	Stroke (Strokes) 01/2022 - 01/2007
25	Ischemic Stroke 01/2022 - 01/2009
7	Infarction (Infarctions) 01/2022 - 02/2009
6	Hypertension (High Blood Pressure) 01/2020 - 01/2009
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 07/2011
4	Embolic Stroke 01/2020 - 08/2014
4	Cerebral Infarction 11/2018 - 03/2010
3	Infections 05/2022 - 01/2013
3	COVID-19 05/2022 - 01/2021
3	Aphasia (Dysphasia) 01/2022 - 11/2018
3	Thrombosis (Thrombus) 01/2022 - 01/2009
3	Hyperglycemia 11/2020 - 10/2010
3	Ischemia 01/2020 - 08/2014
3	Hemorrhage 09/2018 - 07/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2015 - 02/2012
2	Inflammation (Inflammations) 07/2021 - 01/2009
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020 - 01/2015
2	Brain Ischemia (Cerebral Ischemia) 08/2014 - 01/2009
2	Transient Ischemic Attack 04/2012 - 01/2009
2	Cerebral Hemorrhage 01/2012 - 07/2011
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Atherosclerosis 07/2021
1	Wernicke Aphasia (Receptive Aphasia) 01/2021
1	Critical Illness (Critically Ill) 11/2020
1	Broca Aphasia (Expressive Aphasia) 01/2019
1	Paraproteinemias (Monoclonal Gammopathy) 11/2018
1	Multiple Myeloma 11/2018
1	POEMS Syndrome (Syndrome, POEMS) 11/2018
1	Myocardial Infarction 01/2018
1	Diabetes Mellitus 01/2018
1	Leukoaraiosis 01/2018
1	Siderosis 01/2018
1	Hypoxia (Hypoxemia) 01/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 05/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2016
1	Vascular Malformations 01/2016
1	Diplopia (Double Vision) 05/2015
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 05/2015
1	Ataxia (Dyssynergia) 05/2015
1	Neoplasms (Cancer) 02/2015
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2015
1	Hypercholesterolemia 09/2014
1	Brain Infarction 08/2014

Drug/Important Bio-Agent (IBA)

9	AnticoagulantsIBA 01/2020 - 07/2011
6	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 02/2009
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2014
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2009
3	Insulin (Novolin)FDA Link 11/2020 - 10/2010
3	SynaptophysinIBA 01/2019 - 02/2012
3	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2012 - 09/2008
2	salicylhydroxamic acid (SHAM)IBA 11/2020 - 05/2015
2	Streptozocin (Streptozotocin)FDA Link 11/2020 - 01/2019
2	Niacinamide (Nicotinamide)FDA LinkGeneric 11/2020 - 01/2019
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 02/2015
2	A-factor (Streptomyces)IBA 07/2016 - 08/2011
2	Endothelin-1 (Endothelin 1)IBA 06/2015 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 02/2012
2	Antihypertensive Agents (Antihypertensives)IBA 09/2014 - 03/2010
1	fibrin fragment D (D-dimer)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	EnzymesIBA 07/2021
1	ImmunosorbentsIBA 07/2021
1	MicroRNAs (MicroRNA)IBA 07/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	CollagenIBA 01/2019
1	SolutionsIBA 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2018
1	Lenalidomide (CC 5013)FDA Link 11/2018
1	Vitamin K FDA Link 09/2018
1	Blood Glucose (Blood Sugar)IBA 03/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	fedratinibIBA 05/2015
1	Type 1 Angiotensin ReceptorIBA 05/2015
1	olmesartanIBA 05/2015
1	Janus Kinase 2IBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Antiphospholipid AntibodiesIBA 01/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2015
1	2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseIBA 01/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	Myelin Basic ProteinIBA 01/2015
1	Immunoglobulin G (IgG)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2014

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2007
6	Thrombectomy 01/2021 - 05/2016
4	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019 - 10/2012
3	Intravenous Administration 01/2021 - 01/2013
2	Language Therapy (Language Training) 01/2022 - 01/2021
1	Punctures 01/2021
1	Intraperitoneal Injections 11/2020
1	Aftercare (After-Treatment) 09/2018
1	Glycemic Control 01/2018
1	Secondary Prevention 01/2016
1	Patient Transfer (Patient Dumping) 08/2015